Tracon Pharmaceuticals Inc (TCON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,007 | -3,168 | -3,588 | -4,027 | -14,790 |
| Depreciation Amortization | 12 | 8 | 7,359 | 7,352 | 6,675 |
| Accounts receivable | N/A | N/A | N/A | N/A | -9,000 |
| Other Working Capital | -39 | 234 | -2,152 | -694 | -3,813 |
| Other Operating Activity | 722 | 383 | 2,057 | 1,567 | 10,074 |
| Operating Cash Flow | $-5,312 | $-2,543 | $3,676 | $4,198 | $-10,854 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -20,500 | -20,500 | -10,000 |
| Common Stock Issued | 3,018 | 1,870 | 7,961 | 6,637 | 5,228 |
| Financing Cash Flow | $3,018 | $1,870 | $-12,539 | $-13,863 | $-4,772 |
| Beginning Cash Position | 8,637 | 8,637 | 17,500 | 17,500 | 17,500 |
| End Cash Position | 6,343 | 7,964 | 8,637 | 7,835 | 1,874 |
| Net Cash Flow | $-2,294 | $-673 | $-8,863 | $-9,665 | $-15,626 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,312 | -2,543 | 3,676 | 4,198 | -10,854 |
| Free Cash Flow | -5,312 | -2,543 | 3,676 | 4,198 | -10,854 |